Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.
In financial year 2023, Gland Pharma's return on net worth amounted to over 11 percent, compared to 19 percent the previous year. This Indian company was acquired in 2016 by Fosun Pharmaceuticals, a Chinese pharmaceutical company.
Return on net worth by Gland Pharma Limited from financial year 2018 to 2023
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Revenue of Alliance Pharma product brands 2022
- Basic Statistic Revenue of Lundbeck top products 2021-2023
- Basic Statistic Top drugs based on projected 2024 global sales
- Premium Statistic Implementation of pharma track & trace in Russia 2019, by stage
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Basic Statistic Market share of generics in European countries 2021
- Premium Statistic Revenue of the OTC pharmaceuticals industry worldwide 2018-2029
- Basic Statistic Expenditure on prescription pharmaceuticals in Sweden 2009-2023
About the region
10
- Premium Statistic Leading pharmaceutical and drug companies India 2023, by market capitalization
- Basic Statistic EBIT of Godrej Consumer Products FY 2015-2023
- Premium Statistic Hindustan Unilever's return on capital employed FY 2013-2023
- Premium Statistic Hindustan Unilever's investment value FY 2013-2023
- Premium Statistic Hindustan Unilever's earnings per share FY 2013-2023
- Premium Statistic Hindustan Unilever's dividend per share FY 2013-2023
- Premium Statistic Hindustan Unilever's reserves and surplus value FY 2013-2023
- Premium Statistic Hindustan Unilever's gross sales value FY 2013-2023
- Premium Statistic Hindustan Unilever's market capitalization FY 2013-2023
- Premium Statistic Hindustan Unilever's share price in BSE FY 2013-2023
Other regions
10
- Premium Statistic Leading pharmaceutical preparations manufacturers in Spain in 2021
- Basic Statistic Pharmaceutical products and preparations: manufacturers' sales in the UK 2008-2022
- Premium Statistic Biopharmaceuticals market value in Latin America 2022-2027
- Premium Statistic Pharmaceutical self-care companies in Sweden 2018, by sales value
- Premium Statistic Noevir's operating income FY 2015-2019
- Premium Statistic Pharmaceuticals production value in Colombia 2014-2020
- Basic Statistic Reasons for visiting a community pharmacy in Great Britain 2014
- Basic Statistic producer price index of chemical and pharmaceutical products in Norway 2008-2023
- Basic Statistic Revenue of Lundbeck 2009-2023
- Premium Statistic Value of monthly imports of medical and pharmaceutical products Australia 2020-2023
Related statistics
10
- Premium Statistic Lupin's net sales FY 2015-2023
- Premium Statistic Sun Pharma's profit after tax FY 2014-2023
- Premium Statistic Sun Pharma's income FY 2010-2023
- Premium Statistic Cipla's income from operations FY 2014-2023
- Premium Statistic Cipla's profit FY 2009-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
Further related statistics
10
- Revenue of the Bank of Communications 2022
- Revenue of AT&T by segment 2017-2023, by quarter
- Total assets of China Vanke 2022
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Net interest income of Deutsche Bank 2006-2023
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Shareholders equity at Allianz Group 2008-2023
- Total number of shares issued by Allianz Group 2009-2023
- Structure of investment portfolio of Allianz Group 2014-2023
- Sanofi's total assets 2007-2023
Further Content: You might find this interesting as well
Statistics
- Revenue of the Bank of Communications 2022
- Revenue of AT&T by segment 2017-2023, by quarter
- Total assets of China Vanke 2022
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Net interest income of Deutsche Bank 2006-2023
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Shareholders equity at Allianz Group 2008-2023
- Total number of shares issued by Allianz Group 2009-2023
- Structure of investment portfolio of Allianz Group 2014-2023
- Sanofi's total assets 2007-2023
Gland Pharma. (August 8, 2023). Return on net worth by Gland Pharma Limited from financial year 2018 to 2023 [Graph]. In Statista. Retrieved May 09, 2024, from https://www.statista.com/statistics/1186944/gland-pharma-s-return-on-net-worth/
Gland Pharma. "Return on net worth by Gland Pharma Limited from financial year 2018 to 2023." Chart. August 8, 2023. Statista. Accessed May 09, 2024. https://www.statista.com/statistics/1186944/gland-pharma-s-return-on-net-worth/
Gland Pharma. (2023). Return on net worth by Gland Pharma Limited from financial year 2018 to 2023. Statista. Statista Inc.. Accessed: May 09, 2024. https://www.statista.com/statistics/1186944/gland-pharma-s-return-on-net-worth/
Gland Pharma. "Return on Net worth by Gland Pharma Limited from Financial Year 2018 to 2023." Statista, Statista Inc., 8 Aug 2023, https://www.statista.com/statistics/1186944/gland-pharma-s-return-on-net-worth/
Gland Pharma, Return on net worth by Gland Pharma Limited from financial year 2018 to 2023 Statista, https://www.statista.com/statistics/1186944/gland-pharma-s-return-on-net-worth/ (last visited May 09, 2024)
Return on net worth by Gland Pharma Limited from financial year 2018 to 2023 [Graph], Gland Pharma, August 8, 2023. [Online]. Available: https://www.statista.com/statistics/1186944/gland-pharma-s-return-on-net-worth/